ReviewFrontiers in cardiovascular medicine2026
Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy.
Xiao-Hai Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.